德展健康
(000813)
| 流通市值:58.08亿 | | | 总市值:58.09亿 |
| 流通股本:20.97亿 | | | 总股本:20.97亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 229,912,038.77 | 142,633,396.76 | 88,623,591.58 | 396,809,685.19 |
| 营业收入 | 229,912,038.77 | 142,633,396.76 | 88,623,591.58 | 396,809,685.19 |
| 二、营业总成本 | 314,380,971.14 | 195,413,055.78 | 120,004,752.18 | 557,810,924.68 |
| 营业成本 | 127,524,436.14 | 89,705,137.97 | 49,893,740.59 | 173,982,629.51 |
| 税金及附加 | 9,093,498.88 | 5,850,795.96 | 3,509,768.72 | 11,602,778.31 |
| 销售费用 | 52,440,515.69 | 32,403,037.2 | 17,926,055.43 | 82,187,912.14 |
| 管理费用 | 138,224,786.53 | 86,351,021.37 | 38,885,193.1 | 221,958,985.91 |
| 研发费用 | 41,478,581.9 | 28,312,201.04 | 16,805,322.28 | 82,276,358.49 |
| 财务费用 | -54,380,848 | -47,209,137.76 | -7,015,327.94 | -14,197,739.68 |
| 其中:利息费用 | 2,288,988.38 | 1,311,539.78 | 657,668.66 | 2,311,876.42 |
| 其中:利息收入 | 57,520,337.01 | 49,162,796.13 | 7,923,324.82 | 17,222,412.68 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 60,507.99 | 46,935.06 | 28,534.17 | 81,338.21 |
| 加:投资收益 | -12,243,182.23 | -1,427,611.6 | 4,818,187.36 | -27,869,182.51 |
| 资产处置收益 | 64,299.75 | -8,635.4 | -8,625.05 | 1,378,451.21 |
| 资产减值损失(新) | -7,803,583.41 | -3,178,189.5 | -6,101,753.82 | -179,756,793.34 |
| 信用减值损失(新) | -13,177,375.19 | -11,450,536.25 | -9,419,441.74 | -53,833,498.86 |
| 其他收益 | 2,090,699.32 | 1,588,517.8 | 917,797 | 1,666,444.9 |
| 四、营业利润 | -115,477,566.14 | -67,209,178.91 | -41,146,462.68 | -419,334,479.88 |
| 加:营业外收入 | 315,927.58 | 301,546.85 | 286,537.1 | 136,337.01 |
| 减:营业外支出 | 2,029,726.76 | 694,635.03 | 202,814.78 | 1,223,991.68 |
| 五、利润总额 | -117,191,365.32 | -67,602,267.09 | -41,062,740.36 | -420,422,134.55 |
| 减:所得税费用 | 11,384,154 | 7,705,443.61 | 2,105,182.79 | 1,503,693.41 |
| 六、净利润 | -128,575,519.32 | -75,307,710.7 | -43,167,923.15 | -421,925,827.96 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -128,575,519.32 | -75,307,710.7 | -43,167,923.15 | -421,925,827.96 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -103,485,887.83 | -58,198,571.39 | -34,422,944.68 | -345,420,067.59 |
| 少数股东损益 | -25,089,631.49 | -17,109,139.31 | -8,744,978.47 | -76,505,760.37 |
| 扣除非经常损益后的净利润 | -104,129,620.18 | -59,269,501.73 | -35,389,747.67 | -348,951,085.54 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.05 | -0.03 | -0.02 | -0.16 |
| (二)稀释每股收益 | -0.05 | -0.03 | -0.02 | -0.16 |
| 八、其他综合收益 | - | - | - | -60,038,939.79 |
| 归属于母公司股东的其他综合收益 | - | - | - | -60,038,939.79 |
| 九、综合收益总额 | -128,575,519.32 | -75,307,710.7 | -43,167,923.15 | -481,964,767.75 |
| 归属于母公司股东的综合收益总额 | -103,485,887.83 | -58,198,571.39 | -34,422,944.68 | -405,459,007.38 |
| 归属于少数股东的综合收益总额 | -25,089,631.49 | -17,109,139.31 | -8,744,978.47 | -76,505,760.37 |
| 公告日期 | 2026-10-30 | 2026-08-29 | 2026-04-25 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |